registration review complete
on 15 Jun 2023
Last Applicant/ Owned by
CH-4002
Basel
CH
4002
Serial Number
90380256 filed on 14th Dec 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
pharmaceutical preparations acting on the central nervous system The color(s) teal, coral, and white is/are claimed as a feature of the mark. The mark consists of two transverse stripes, one teal and one coral, applied side by side near the middle of a three-dimensional injection pen; the teal stripe is plain, the coral stripe is inscribed with a series of small stylized arrows pointing in one dRead More
pharmaceutical preparations acting on the central nervous system
01st Oct 2020
01st Oct 2020
No 90380256
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
10.07.25 -
Other medical or surgical apparatus, instruments, attire, or utensils, including medical inhalers and eyepatches
24.15.04 -
Arrowheads
24.15.10 -
More than one arrow
The mark consists of two transverse stripes, one teal and one coral, applied side by side near the middle of a three-dimensional injection pen; the teal stripe is plain, the coral stripe is inscribed with a series of small stylized arrows pointing in one direction bordered by one and a half rounded white arrows pointing in the other direction; the logo OMB, with the "O" in coral and the combined letters "MB" in teal, appears one inch below the teal stripe; the dotted lines are for placement only and are not a part of the mark.
| Status Date | Action Taken |
|---|---|
| 16th Jun 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 15th Jun 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 30th May 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 30th May 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 05th May 2023 | USE AMENDMENT FILED |
| 05th May 2023 | TEAS STATEMENT OF USE RECEIVED |
| 29th Nov 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Nov 2022 | SOU EXTENSION 2 GRANTED |
| 27th Nov 2022 | SOU EXTENSION 2 FILED |
| 27th Nov 2022 | TEAS EXTENSION RECEIVED |
